ConductScience.org, home

Paper41968952

Pulsed field ablation: from technological breakthrough to structured clinical implementation-the role of the European Heart Rhythm Association.

Pürerfellner H and 4 others. Europace, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Pulsed field ablation: from technological breakthrough to structured clinical implementation-the role of the European Heart Rhythm Association. Papers, record 41968952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41968952

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pulsed field ablation: from technological breakthrough to structured clinical implementation-the role of the European Heart Rhythm Association.
PubMed
Journal
Europace
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Atrial FibrillationMajor topic
CardiologyMajor topic
Irreversible Electroporation TherapyMajor topic
Humans
Diffusion of Innovation
Europe
Societies, Medical
Treatment Outcome

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1392986652024 updated European Heart Rhythm Association core curriculum for physicians and allied professionals: a statement of the European Heart Rhythm Association of the European Society of Cardiology.Europace2024https://conductscience.org/library/papers/39298665PubMed
240888735Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry.Europace2025https://conductscience.org/library/papers/40888735PubMed
340845172Incidence of laboratory-defined severe intravascular haemolysis across commercially available pulsed field ablation technologies for atrial fibrillation.Europace2025https://conductscience.org/library/papers/40845172PubMed
440802569EHRA perspective on the digital data revolution in arrhythmia management: insights from the association's annual summit.Europace2025https://conductscience.org/library/papers/40802569PubMed
541248987Characterization of sedation strategies in real-world use of pulsed field ablation Sub-analysis of the EU-PORIA registry.Europace2025https://conductscience.org/library/papers/41248987PubMed
6416904392026 HRS/EHRA scientific statement on pulsed field ablation for cardiac arrhythmias.Heart Rhythm2026https://conductscience.org/library/papers/41690439PubMed
738385529Long-term outcomes of the pentaspline pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation: results of the prospective, multicentre FARA-Freedom Study.Europace2024https://conductscience.org/library/papers/38385529PubMed
841363248Pulsed field ablation for atrial fibrillation ablation: a European Heart Rhythm Association survey.Europace2025https://conductscience.org/library/papers/41363248PubMed
941125244Anterior mitral isthmus line using pulsed-field ablation with the pentaspline catheter or radiofrequency ablation: procedural characteristics, safety, and mid-term outcomes.Europace2025https://conductscience.org/library/papers/41125244PubMed
1040697128Arrhythmia care in ESC member countries: the 2025 ESC-EHRA atlas on heart rhythm disorders.Europace2025https://conductscience.org/library/papers/40697128PubMed
1138848447State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective.Europace2024https://conductscience.org/library/papers/38848447PubMed
1239077807Same-day discharge vs. overnight stay following catheter ablation for atrial fibrillation: a comprehensive review and meta-analysis by the European Heart Rhythm Association Health Economics Committee.Europace2024https://conductscience.org/library/papers/39077807PubMed
1341968953
Pulsed field ablation for the interventional treatment of atrial fibrillation: a scientific statement of the European Heart Rhythm Association of the European Society of Cardiology, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society.
Europace2026https://conductscience.org/library/papers/41968953PubMed
1441437309Controversy: pulsed field ablation is the standard technique for all the candidates for atrial fibrillation ablation.Europace2025https://conductscience.org/library/papers/41437309PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42739524Phenotype-Guided Management of Atrial Fibrillation in Heart Failure: From Rate Control to Catheter Ablation.J Clin Med2026https://conductscience.org/library/papers/42739524

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41968952

GET https://conductscience.org/api/papers/v1/41968952/authors